Evidence map›Paper›PMID 40002350›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Myocardial

Fatma Bayram, Philipp Hegner, Anna-Maria Lauerer, Sönke Schildt, Dominik Wermers, Maria Johanna Baier, Julian Mustroph, Maria Tafelmeier, Zdenek Provaznik, Christof Schmid and 4 more

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Fatma BayramDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0009-0003-7230-3473
Philipp HegnerDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0003-1776-777X
Anna-Maria LauererDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0009-0007-5054-3854
Sönke SchildtDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-7245-6902
Dominik WermersDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.
Maria Johanna BaierDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0003-1722-7976
Julian MustrophDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.
Maria TafelmeierDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0003-3778-6716
Zdenek ProvaznikDepartment of Cardiothoracic Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Christof SchmidDepartment of Cardiothoracic Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Lars Siegfried MaierDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.
Stefan WagnerDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-9471-1166
Michael ArztDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.
Simon LebekDepartment of Internal Medicine II, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0003-4525-797X

Funding

Else-Kröner-Fresenius Foundation doctoral networkElse-Kröner-Fresenius Foundation project number: 2018_A159EU Horizon STRATIFY-HF (project number: 101080905)German Cardiac Society Clinician Scientist ProgramGerman Federal Ministry of Education and Research project number: 01ZZ2324CGerman Heart Foundation (Deutsche Herzstiftung e.V.) Research GrantGerman Research Foundation Heisenberg-Professorship (LE 5009/2-1, project number: 528296867)German Research Foundation LE 5009/3-1, project number: 528297116German Research Foundation LE 5009/5-1, project number: 554804344German Research Foundation TRR 374 grant (project number: 509149993, TPA6)German Research Foundation WA 2539/8-1
6 · The paper itself

Abstract

Heart failure and cardiovascular disease represent a significant burden on healthcare systems worldwide. Recent evidence associates an increased expression of the dual-specificity tyrosine phosphorylation-regulated kinase 1B (DYRK1B) with an impaired cardiac function in mice. However, there remains a paucity of data on myocardial

Indexed as

cardiovascular diseaseDYRK1Bheart failurehypoxiasleep-disordered breathing

Identifiers

PMID40002350
PMCPMC11851367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.